🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Happy holidays from the Alto Team! We're planning to spend this holiday season prioritizing our mental health and spending some time with family and loved ones.

Happy New Year from everyone at Apeiron Investment Group. Here’s to a wonderful 2024 for all! 🎉🍾🥳🎇

#Psychiatry is an ever-changing field, and treatment options will continue to evolve in 2024. At Alto, we are passionate about developments in the #MentalHealth treatment landscape and furthering our mission to bring personalized, effective treatments to people in need.

Don't miss our founder, Christian Angermayer, in conversation with The Dales Report about the thawing of the biotech winter and atai Life Sciences's strategic investment in Beckley Psytech. #NextHumanAgenda #Psychedelics #Biotech thedalesreport.com/psychedelics/h…

#DYK that our clinical-stage pipeline includes novel drug candidates in #Depression, #PTSD, #Schizophrenia, and other #MentalHealth conditions? Learn more about our pipeline and target indications: brnw.ch/21wG7uo

Our product candidates in development target core #brain processes, including: 🧠 Cognition 🙂 Emotion and its regulation 💤 Sleep and circadian rhythms Learn more: brnw.ch/21wGjyK

re.Mind Capital is proud to have been part of motif neurotech's Series A raise. Congrats to Jacob Robinson and his team! The work they're doing to develop an implantable device for treatment-resistant depression will help transform the future of #mentalhealth #neurotech

We are one of the top 50 places to work! 🙌 We're delighted to have been named one of Built In's top 50 places to work – both in-person and remotely. This speaks to our dedication to creating a global workplace that inspires innovation, champions our team, and supports the

A huge congratulations to Amit Etkin and the entire Alto Neuroscience team for reaching this IPO milestone. We're proud investors and supporters of their vision, and we can't wait to see what the next chapter holds in store. 🧠 #NextHumanAgenda #Biotech #AI

Congratulations Alto Neuroscience !!! #mentalhealth

We are thrilled to welcome Dr. Husseini Manji to Alto’s Board of Directors. Bringing decades of experience spanning both industry and academia, Dr. Manji embodies Alto’s value “Invested in Impact” through his commitment to redefining #psychiatric treatment for patients.

All things leadership 🎙️ We’re curious about the advice of some of the greatest leaders in healthcare. Tune into this episode of The Cure(ious) nyse.com/insights/the-c…

At Alto, everything we do is rooted in our core values. We aim to defeat the global #MentalHealth crisis one brain at a time. For us, it's about the differences we make in the lives of every person we impact. Learn more about our values and mission here: brnw.ch/21wH0pr

Our team: data scientists 🤝 clinical experts. We put data at the forefront of our work to inform our #PrecisionPsychiatry approach. Learn how we are working to eliminate trial-and-error from #MentalHealth drug development: brnw.ch/21wHbsn

We're looking for a Research Sales Specialist to hire. If you've got a passion for technology and want to collaborate with top research institutions on groundbreaking neuroscience, we want to hear from you. Apply here: ats.rippling.com/blackrockneuro…

For insight into how a pre-revenue #BCI company approaches reimbursement strategy at this stage, our Chief Commercial Officer Kurt Haggstrom speaks with @forbes columnist Naveen Rao forbes.com/sites/naveenra…

We recently initiated a Phase 2 study of ALTO-203 in people with MDD & higher levels of #anhedonia. We look forward to continuing to study the potential of #PrecisionPsychiatry. Check out this Psychiatric Times article to learn more: brnw.ch/21wIEKC

Check out this Reuters story about re.Mind Capital portfolio company, Synchron - one of the true leaders in brain-computer interfaces and #neurotech.

📅 One week to go before Tech Tour Mental & Brain Health event! EBC’s Deputy Executive Director Stephanie Kramer is pleased to join the panel discussion “Is – or how can we make – mental health and brain health a government policy priority?”. 🔍 braincouncil.eu/event/tech-tou…